Published Paper Details:

Diabetic neuropathy is a common and early complication of diabetes, but its understanding and effective treatment have presented challenges. The pathophysiology of neuropathy in diabetes is complex, and this, along with the lack of a straightforward treatment regimen, may have contributed to insufficient attention to this complication. However, there have been gradual advancements in the clinical management of diabetic neuropathy, including the proposal of diagnostic criteria and clinical staging for early detection of nerve deficits and treatment guidance. Recent progress in the pathogenesis of diabetic neuropathy has been made, shedding light on the underlying pathology of this condition. The emergence of pain-relieving agents has also contributed to improving the quality of life for patients experiencing symptomatic neuropathy. Despite these advances, there is still a need for a clearer understanding of the mechanisms leading to the development of diabetic neuropathy, the identification of reliable clinical indices for nerve deficits, and the prediction of prognosis. In summary, while diabetic neuropathy poses challenges, ongoing research and advancements in clinical management are gradually improving our understanding and ability to address this complication associated with diabetes.